NLRP3 and obstructive sleep apnea syndrome: For example, NLRP3 overexpression is associated with high levels of oxidized low-density lipoprotein (oxLDL) in plasma from OSA patients with early subclinical atherosclerosis [82], indicating an interaction between dyslipidemia and inflammation in inducing tissue injury.